Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization : insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
dc.contributor.author | Nicolau, Jose Carlos | |
dc.contributor.author | Bhatt, Deepak L. | |
dc.contributor.author | Roe, Matthew T. | |
dc.contributor.author | Lokhnygina, Yuliya | |
dc.contributor.author | Neely, Benjamin | |
dc.contributor.author | Corbalán Herreros, Ramón | |
dc.contributor.author | Leiva-Pons, José L. | |
dc.contributor.author | Martinez, Felipe | |
dc.contributor.author | Goodman, Shaun G. | |
dc.contributor.author | Winters, Kenneth J. | |
dc.contributor.author | Verheugt, Freek W.A. | |
dc.contributor.author | Armstrong, Paul W. | |
dc.contributor.author | White, Harvey D. | |
dc.contributor.author | Fox, Keith A. A. | |
dc.contributor.author | Prabhakaran, Dorairaj | |
dc.contributor.author | Ohman, E. Magnus | |
dc.date.accessioned | 2021-05-24T20:26:42Z | |
dc.date.available | 2021-05-24T20:26:42Z | |
dc.date.issued | 2015 | |
dc.fuente.origen | Converis | |
dc.identifier.doi | 10.1016/j.ahj.2015.05.017 | |
dc.identifier.eissn | 1097-6744 | |
dc.identifier.issn | 0002-8703 | |
dc.identifier.uri | https://doi.org/10.1016/j.ahj.2015.05.017 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/59366 | |
dc.identifier.wosid | WOS:000361575200010 | |
dc.issue.numero | No. 4 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido parcial | |
dc.pagina.final | 694.e3 | |
dc.pagina.inicio | 683 | |
dc.revista | American Heart Journal | es_ES |
dc.rights | acceso restringido | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.ods | 03 Good health and well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.subject.other | Arterias coronarias - Enfermedad - tratamiento farmacológico | es_ES |
dc.subject.other | Activación de plaquetas - Efectos de fármacos | es_ES |
dc.subject.other | Coronariopatía | es_ES |
dc.title | Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization : insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 170 | |
sipa.codpersvinculados | 98700 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization.pdf
- Size:
- 113 KB
- Format:
- Adobe Portable Document Format
- Description: